KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) EBT Margin (2016 - 2025)

Novavax (NVAX) has 16 years of EBT Margin data on record, last reported at 12.17% in Q4 2025.

  • For Q4 2025, EBT Margin rose 9549.0% year-over-year to 12.17%; the TTM value through Dec 2025 reached 41.74%, up 6763.0%, while the annual FY2025 figure was 39.36%, 6525.0% up from the prior year.
  • EBT Margin reached 12.17% in Q4 2025 per NVAX's latest filing, up from 288.22% in the prior quarter.
  • Across five years, EBT Margin topped out at 77.98% in Q1 2025 and bottomed at 373.39% in Q4 2021.
  • Average EBT Margin over 5 years is 99.7%, with a median of 65.48% recorded in 2023.
  • Peak YoY movement for EBT Margin: skyrocketed 71676bps in 2021, then plummeted -39088bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 373.39% in 2021, then surged by 86bps to 51.63% in 2022, then decreased by -17bps to 60.65% in 2023, then crashed by -37bps to 83.32% in 2024, then surged by 115bps to 12.17% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 12.17% in Q4 2025, 288.22% in Q3 2025, and 61.4% in Q2 2025.